San Francisco, CA, United States of America

Catherine Sabatos

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Catherine Sabatos

Introduction

Catherine Sabatos is a prominent inventor located in San Francisco, CA. She has made significant contributions to the field of immunology through her inventiveness, securing a patent that reflects her commitment to advancing medical science.

Latest Patents

Catherine holds a patent for "Tim-3 ligands and methods thereof." This invention pertains to isolated polypeptides and nucleic acids that encode polypeptides featuring a Tim-3 IgV domain and a Tim-3 intracellular domain. Notably, these polypeptides do not include a Tim-3 mucin domain or a Tim-3 transmembrane domain. Furthermore, her invention addresses methods for modulating immune responses in subjects by administering a therapeutically effective amount of agents that influence Tim-3 activity. The immune responses targeted by this invention encompass immune tolerance, transplantation tolerance, as well as Th1 and Th2 responses.

Career Highlights

Throughout her career, Catherine has collaborated with esteemed research institutions and has been associated with notable organizations such as The Brigham and Women's Hospital and Beth Israel Deaconess Medical Center. Her work within these institutions highlights her dedication to enhancing our understanding of immune responses and therapeutic strategies.

Collaborations

Catherine has worked alongside notable colleagues in the field, including Vijay K. Kuchroo and Terry Barton Strom. These collaborations have helped to enrich her research and drive innovation in therapeutic approaches related to immune responses.

Conclusion

Catherine Sabatos stands out as an influential inventor whose work in immunology is paving the way for future advancements in medicine. With her patent and collaborative efforts, she continues to contribute to the evolution of understanding immune responses, thus making significant strides towards improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…